STOCK TITAN

Twist Bioscience CEO Emily M. Leproust sells 19,045 shares

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

Twist Bioscience Corp (TWST) CEO Emily M. Leproust sold 19,045 shares at $103.6880 per share on November 16, 2026. The sale covered tax withholding tied to vesting of Performance Stock Units and was required by the issuer's equity plans, not discretionary. Leproust also received 36,413 restricted stock units; 1/16 vests each quarterly anniversary of November 16, 2026 over 48 months, subject to continuous service. The reported direct options included 131,290 shares at a $23.33 exercise price, expiring October 23, 2029, and 64,950 shares at $67.85, expiring August 31, 2030.

Insider Leproust Emily M.
Role Chief Executive Officer
Sold 19,045 shs ($1.97M)
Share of Position Sold 2.9%
Type Security Shares Price Value
Sale Common Stock F1 19,045 $103.688 $1.97M
Grant/Award Common Stock F2 36,413 $0.00 $0.00
Holding Employee Stock Option (right to buy) F3 -- -- --
Holding Employee Stock Option (right to buy) F4 -- -- --
Holdings After Transaction: Common Stock — 670,906 shares (Direct); Employee Stock Option (right to buy) — 196,240 options (Direct)
Holdings Before and After: Common Stock, 653,538 to 670,906 shares (Direct)
Other Insiders: 5 other insiders reported open-market sales of this stock in the 30 days up to this filing.
Footnotes (4)
  1. F1. Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Performance Stock Units (""PSUs""). These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a ""sell to cover"" transaction and do not represent discretionary trades by the Reporting Person.
  2. F2. Represents a restricted stock unit award ("RSU") of which 1/16th of the total number of RSUs vest on each quarterly anniversary of November 16, 2026 for a total vesting period of 48 months, subject to the Reporting Person's continuous service through each vesting date.
  3. F3. 25% of the shares subject to the option vested on October 24, 2020, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
  4. F4. Represents performance stock options granted to the reporting person on September 1, 2020, that vested and became exercisable on December 19, 2022 as a result of the reporting person having met the applicable performance criteria.
Shares sold 19,045 shares Sale on November 16, 2026 to cover tax withholding tied to Performance Stock Unit vesting
Sale price $103.6880 per share Sale on November 16, 2026
Restricted stock unit award 36,413 restricted stock units Award on November 16, 2026
RSU vesting period 48 months One-sixteenth vests on each quarterly anniversary of November 16, 2026, subject to continuous service
Option underlying shares 131,290 shares Direct options with a $23.33 exercise price, expiring October 23, 2029
Option exercise price $23.33 per share Direct options covering 131,290 underlying shares
Option underlying shares 64,950 shares Direct performance stock options with a $67.85 exercise price, expiring August 31, 2030
Option exercise price $67.85 per share Direct performance stock options covering 64,950 underlying shares
sell to cover financial
"the required sell to cover transaction for tax withholding"
Sell to cover is when a person who receives company stock through options or awards sells just enough shares immediately to pay required taxes, exercise costs, or fees, keeping the rest. Think of it like cashing part of a bonus to cover the tax bill so you can keep the remainder. For investors, it can create predictable small selling pressure and slightly change the number of shares actually held by insiders without increasing long‑term dilution.
Performance Stock Units financial
"tax withholding obligations tied to vesting of Performance Stock Units"
Performance stock units are a type of company award that grants employees shares of stock only if certain performance goals are met. They motivate employees to work toward specific company achievements, aligning their interests with those of shareholders. For investors, they can influence a company's future stock supply and reflect management’s confidence in reaching key targets.
restricted stock unit award financial
"a restricted stock unit award with quarterly vesting"
A restricted stock unit award is a promise by a company to give an employee a specified number of company shares at a future date if certain conditions are met, such as staying with the company or hitting performance goals. For investors, these awards matter because they can increase the total number of shares outstanding when converted, diluting existing holders, and they align employees’ incentives with shareholders’ interests much like giving a rising bonus that becomes real only after conditions are satisfied.
performance stock options financial
"performance stock options vested and became exercisable"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many shares did TWST CEO Emily M. Leproust sell and at what price?

Emily M. Leproust sold 19,045 shares at $103.6880 per share on November 16, 2026. The shares were sold to cover tax withholding associated with vesting of Performance Stock Units; the issuer's equity-plan requirement made the sale nondiscretionary. No Rule 10b5-1 plan is reported.

What were the vesting terms of Emily M. Leproust's TWST RSU award?

She received 36,413 restricted stock units on November 16, 2026. One-sixteenth of the award vests on each quarterly anniversary of that date over 48 months, subject to her continuous service through each vesting date.

What are the vesting terms of Emily M. Leproust's TWST options?

One direct option position covered 131,290 underlying shares at a $23.33 exercise price; 25% vested October 24, 2020, followed by 1/48 on each monthly anniversary, subject to continuous service. A separate 64,950-share performance option grant vested and became exercisable December 19, 2022, after the applicable performance criteria were met; it has a $67.85 exercise price and expires August 31, 2030.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Leproust Emily M.

(Last)(First)(Middle)
C/O TWIST BIOSCIENCE CORPORATION
681 GATEWAY BLVD.

(Street)
SOUTH SAN FRANCISCO CALIFORNIA 94080

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Twist Bioscience Corp [ TWST ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
Chief Executive Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/16/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock11/16/2026S19,045(1)D$103.688634,493D
Common Stock11/16/2026A36,413(2)A$0670,906D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Employee Stock Option (right to buy)$23.33 (3)10/23/2029Common Stock131,290131,290D
Employee Stock Option (right to buy)$67.8512/19/202208/31/2030Common Stock64,95064,950(4)D
Explanation of Responses:
1. Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Performance Stock Units (""PSUs""). These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a ""sell to cover"" transaction and do not represent discretionary trades by the Reporting Person.
2. Represents a restricted stock unit award ("RSU") of which 1/16th of the total number of RSUs vest on each quarterly anniversary of November 16, 2026 for a total vesting period of 48 months, subject to the Reporting Person's continuous service through each vesting date.
3. 25% of the shares subject to the option vested on October 24, 2020, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
4. Represents performance stock options granted to the reporting person on September 1, 2020, that vested and became exercisable on December 19, 2022 as a result of the reporting person having met the applicable performance criteria.
Remarks:
/s/ Kendra Fox, as Attorney-in-Fact for Emily M. Leproust11/18/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading